I‘ve had little time this past pandemic year to indulge in my passion for science around the color blue. But I did take some time this week to write about a cool paper describing a potential new blue food dye.
Story is here, quick thread on blue to come:
Yes, finding new blue food colorants is a whole thing.
The world mostly relies on brilliant blue, E131, and indigotine, E132. Both of these are synthetic, however, and there has been a push by consumers and companies for natural alternatives.
So the race has been on to find natural alternatives and I‘ve written about this before here:
There is one alternative that is now sometimes used: a crude extract of spirulina algae. sciencemag.org/news/2019/05/m…
But like many natural blues, spirulina has a lot of purple undertones. That is especially problematic when you want to blend the blue with yellow to get a good green. As @PamDenish tod me: „Purple plus yellow equals brown, so you’re not going to get a very vibrant green.“
Here is an image from the paper comparing different blues and the greens they yield in coatings of sugar lentils:
(The research was done with scientists at Mars Wrigley, so yes this is about the possible future color of your M&Ms too)
(Ooops. „Real“ work calling. Will continue after.)
Back to blue: In plants the only pigments that can „make“ blue are anthocyanins.
Anthocyanins are fascinating beause they are literally named for „blue flowers“, but mostly in nature we encounter them in red: Take strawberries, red roses or autumn leaves.
You can easily turn these molecules blue if you increase the pH, so make their surroundings less acidic: Cut and boil some red cabbage and the water will be purple. Add lemon juice and it turns red. Add baking powder it turns blue.
Most flowers don‘t have this option. So the cornflower does some crazy chemistry to turn its petals blue: It builds huge complexes of anthocyanin molecules plus other molecules arranged around central
metal ions. That stabilizes the „blue“ version of the anthocyanins.
The researchers of the new paper decided to basically pick one of the anthocyanins of red cabbage that seemed particularly promising, so one part of that blue soup you get from red cabbage and baking powder (there are a lot of slightly different anthocyanins in there).
When they added aluminum ions they found that this particular molecule, they just call it P2, arranged itself in a way reminiscent of the cornflower: In this case three molecules arranged around the central ion. That made the molecule more stable and gave a better blue.
One problem remained: This molecule represents just about 5% of the anthocyanins in red cabbage. Looking for ways to increase yield, the scientists decided to look for enzymes that could convert some of the other anthocyanins in red cabbage into the P2 they wanted.
Indeed they found a bacterial enzyme that did quite well and they designed it to be even better at this through a mutation. After this enzyme has done its job about half the anthocyans of the red cabbage are P2. Pretty cool.
This does not mean, however, that there is going to be new blue M&M‘s soon. For one, the yield is still low: about 75 milligrams of blue from 100 grams of red cabbage.
More importantly, safety and long-term stability of this dye still need to be thoroughly assessed.
As @bastoslab told me: „the perfect new blue dye must combine: high tinctorial power, broad applicability, low toxicity and environmental impact, low production cost and efficient synthesis, have a hue that people like and perhaps use natural products as starting materials“
So red cabbage may end up giving us a new blue - or it may not.
But it‘s another example of the complexity you can find when you delve into the science and the beauty of blue.
I should know, I wrote a whole book about it, coming out later this year: amazon.com/Blue-Search-Na…
“We have now seen seven consecutive weeks of increasing cases and four weeks of increasing deaths”, says @DrTedros at @WHO presser on #covid19. “Last week was the fourth highest number of cases in a single week so far."
@DrTedros@WHO "This is despite the fact that more than 780 million doses of vaccine have now been administered globally”, says @DrTedros.
"Make no mistake, vaccines are a vital and powerful tool, but they are not the only tool."
@DrTedros@WHO “Confusion, complacency and inconsistency in public health measures, and their application are driving transmission and costing lives”, says @DrTedros.
"It takes a consistent, coordinated and comprehensive approach."
Like everything in this pandemic the science around the rare clotting disorder seen in AstraZeneca vaccinees has moved at an incredible pace. As the link has become clear, hints for a cause have emerged
Story with @GretchenVogel1 is here, thread to come: sciencemag.org/news/2021/04/h…
@GretchenVogel1 As we explained in an earlier story, the combination of thromboses in unusual places and a low platelet count, quickly led researchers to think of HIT (heparin-induced thrombocytopenia), a rare side effect in people given the blood thinner heparin.
@GretchenVogel1 On Friday, reports from a group in Germany and one in Norway appeared in @NEJM. Both show that the patients have some of the hallmarks of HIT, like antibodies against platelet factor 4 and platelet activation. nejm.org/doi/full/10.10… nejm.org/doi/full/10.10…
“Out of 220 countries and economies, 194 have now started vaccination and 26 have not”, says @DrTedros at #covid19@WHO presser. “Of those, seven have received vaccines and could start, and a further five countries should receive their vaccines in the coming days."
@DrTedros@WHO (Tomorrow is day 100 of the year and @WHO had called on vaccinations against #covid19 to begin in all countries within the first 100 days of the year.)
@DrTedros@WHO The remaining 14 countries have not yet begun #Covid19 vaccination for a range of reasons, says @DrTedros. "Some have not requested vaccines through COVAX, some are not yet ready, and some plan to start in the coming weeks and months."
"I want to start by stating that our safety committee the pharmacovigilance risk assessment committee of the European Medicines Agency has confirmed that the benefits of the AstraZeneca vaccine in preventing #COVID19 overall outweigh the risks of side effects”, says Emer Cooke.
“The PRAC, after a very in depth analysis, has concluded that the reported cases of unusual blood clotting following vaccination with the AstraZeneca vaccine should be listed as possible side effects of the vaccine”, says Cooke.
“Based on the current available evidence, specific risk factors such as age, gender, or previous medical history of clotting disorders have not been able to be confirmed as the rare events are seen in all ages, and in men and women”, says Cooke.
15 Monate lang habe ich jetzt intensiv über diese Pandemie berichtet.
Ich habe mich in die Arbeit gestürzt, weil genau das hier mein Job ist. Aber auch weil es die Chance war etwas zu tun, sich nicht so nutzlos zu fühlen.
Ich habe mit Forscherinnen und Ärzten gesprochen, Artikel geschrieben, getwittert, einen Podcast gestartet, habe Panels moderiert, Pressekonferenzen gelauscht und Interviews gegeben.
Ich war häufig frustriert, gestresst, manchmal traurig.
Aber in dieser ganzen Zeit habe ich das schiere Ausmaß des Leids, das dieses winzige Virus verursacht hat, ziemlich erfolgreich von mir ferngehalten.
Drei. Millionen. Tote. Wie beginnt man das zu begreifen?
My colleagues and I have decided to spend a few episodes of our @pandemiapodcast talking about the search for an HIV vaccine and parallels and differences with #covid19.
First episode (in German) here, a few thoughts (in English) to come:
@pandemiapodcast It’s worth noting that we are coming up on 40 years since the first report appeared on what would turn into the devastating AIDS pandemic. On 5 June 1981, @CDCMMWR reported on 5 young men in Los Angeles with a rare pneumonia caused by a fungus, 2 had died
@pandemiapodcast@CDCMMWR One month later, there were 26 similar cases reported in @CDCMMWR (cssh.northeastern.edu/pandemic-teach…).
As Tony Fauci told us:
"At that point, it dawned upon me, we have a really serious problem. And this is very likely a new disease, likely a virus."